ITMCTR2100005028
Not yet recruiting
Phase 1
A randomized, double-blind, parallel-controlled, multi-center clinical trial of the effectiveness and safety of Fuyanxiao Capsule in the treatment of pelvic inflammatory diseases (damp-heat stasis syndrome)
Dongfang Hospital, Beijing University of Chinese Medicine0 sitesTBD
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dongfang Hospital, Beijing University of Chinese Medicine
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •For a qualified subject, the answer to all the selection criteria must be yes.
- •1\.Meet the diagnostic criteria of Western medicine for pelvic inflammatory diseases;
- •2\.Patients who meet the TCM syndrome of damp\-heat stasis;
- •3\.Aged 20 to 50 years, married or have a history of sexual life;
- •4\.45\.Lower abdominal pain VAS \>\= 4 points;
- •6\.Axillary body temperature\<\=38\.0?;
- •7\.The patient himself gave informed consent and signed the informed consent form.
Exclusion Criteria
- •For a qualified subject, the answer to all exclusion criteria must be No:
- •1\.Combined with medical history and physical signs, auxiliary examinations include appendicitis, ectopic pregnancy, torsion of ovarian cyst pedicle, pelvic hemorrhage, rupture of ovarian cyst, gastroenteritis, sequelae of pelvic inflammatory disease, endometriosis, adenomyosis And related symptoms caused by Neisseria gonorrhoeae infection;
- •2\.Patients are pregnant, lactating or planning to become pregnant in the near future;
- •3\.Routine blood white blood cell count\> 1\.1 times the upper limit of normal, and blood routine neutrophil percentage\> 90%;
- •4\.Patients are in critical condition or have surgical indications, such as complicated fallopian tube ovarian abscess, pelvic abscess, diffuse peritonitis, sepsis, etc.;
- •5\.Patients with serious primary diseases and mental illnesses of the heart, brain, liver, kidney, hematopoietic and immune systems;
- •6\.Patients have taken relevant Chinese and Western medicines for the treatment of this disease within 1 month before enrollment, and the curative effect of the medicine is difficult to judge;
- •7\.Patients are allergic to the drug components of the known test drugs;
- •8\.Alanine aminotransferase (ALT), aspartate aminotransferase (AST) greater than 1\.2 times the upper limit of normal, and blood creatinine (Cr) greater than the upper limit of normal;
- •9\.Participate in other clinical studies within 1 month before screening.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A randomized, double-blind, parallel-controlled, multicenter trial to evaluate the effectiveness and safety of Xiyanping injection combined with azithromycin and azithromycin in the treatment of mycoplasma pneumoniae pneumonia in childreMycoplasma pneumoniae pneumoniaITMCTR2000003093The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Recruiting
Phase 4
A randomized, double-blind, parallel-controlled, multi-center clinical trial of Chinese medicine variety protection with Niuhuang Qinggan Capsule in the treatment of common cold (wind-heat syndrome)Common cold (wind-heat syndrome)ITMCTR2200005537The Second Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine
Recruiting
Phase 4
A randomized, double-blind, parallel-controlled, multi-center clinical trial of traditional Chinese medicine variety protection with Wuhu Oral Liquid in the treatment of acute soft tissue injury (Qi stagnation and blood stasis syndrome)acute soft tissue injuryITMCTR2200005606onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Recruiting
Phase 4
A randomized, double-blind, parallel-controlled, multicentre clinical study to evaluate the efficacy and safety of Sechang Zhixie Powder in the treatment of acute watery diarrhea in childreAcute watery diarrheaITMCTR2100004284First Teaching Hospital of Tianjin University of TCM
Recruiting
Phase 2
Phase II Clinical Trial of Qingke Pingchuan Granules in Treating Acute Bronchitis in ChildreAcute bronchitis in childrenITMCTR2100004581Shanghai Traditional Chinese Medicine Hospital